Economic implications of screening strategies in arteriovenous fistulae

Kidney International

Volumn 69, Issue 12, 2006, Pages 2219-2226

  Tonelli, M ^a,b   Klarenbach, S ^a,b   Jindal, K ^a   Manns, B ^b,c,d  

^a UNIVERSITY OF ALBERTA   (Canada)

^b INSTITUTE OF HEALTH ECONOMICS   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d FOOTHILLS HOSPITAL   (Canada)

Author keywords

Arteriovenous shunt; Arteriovenous surgical; Hemodialysis; Vascular access

Indexed keywords

ADULT; ANGIOGRAPHY; ARTERIOVENOUS FISTULA; ARTICLE; BLOOD FLOW; COMPARATIVE STUDY; ECONOMIC ASPECT; FEMALE; HEALTH CARE COST; HUMAN; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; SCREENING; SENSITIVITY ANALYSIS; STENOSIS; THROMBOSIS;

ANGIOGRAPHY; ANGIOPLASTY; ARTERIOVENOUS SHUNT, SURGICAL; BLOOD FLOW VELOCITY; CONSTRICTION, PATHOLOGIC; COST-BENEFIT ANALYSIS; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MASS SCREENING; RENAL DIALYSIS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33745079302     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5000151     Document Type: Article

References (28)

1. Tonelli M, Jhangri GS, Hirsch DJ et al. Best threshold for diagnosis of stenosis or thrombosis within six months of access flow measurement in arteriovenous fistulae. J Am Soc Nephrol 2003; 14: 3264-3269.
2. Tessitore N, Bedogna V, Gammaro L et al. Diagnostic accuracy of ultrasound dilution access blood flow measurement in detecting stenosis and predicting thrombosis in native forearm arteriovenous fistulae for hemodialysis. Am J Kidney Dis 2003; 42: 331-341.
3. Jindal KK, Ethier J, Lindsay RM et al. Clinical practice guidelines for vascular access. Canadian Society of Nephrology. J Am Soc Nephrol 1999; 10: S287-S321.
4. McCarley P, Wingard RL, Shyr Y et al. Vascular access blood flow monitoring reduces access morbidity and costs. Kidney Int 2001; 60: 1164-1172.
5. Tonelli M, Jindal K, Hirsch D et al. Screening for subclinical stenosis in native vessel arteriovenous fistulae. J Am Soc Nephrol 2001; 12: 1729-1733.
6. Tessitore N, Lipari G, Poli A et al. Can blood flow surveillance and pre-emptive repair of subclinical stenosis prolong the useful life of arteriovenous fistulae? A randomized controlled study. Nephrol Dial Transplant 2004; 19: 2325-2333.
7. Schwarz C, Mitterbauer C, Boczula M et al. Flow monitoring: performance characteristics of ultrasound dilution versus color Doppler ultrasound compared with fistulography. Am J Kidney Dis 2003; 42: 539-545.
8. Haage P, Vorwerk D, Wildberger JE et al. Percutaneous treatment of thrombosed primary arteriovenous hemodialysis access fistulae. Kidney Int 2000; 57: 1169-1175.
9. Manns B, Tonelli M, Yilmaz S et al. Establishment and maintenance of vascular access in incident hemodialysis patients: a prospective cost analysis. J Am Soc Nephrol 2005; 16: 201-209.
10. Mehta S. Statistical summary of clinical results of vascular access procedures for haemodialysis. In: Sommer BG, HM WL (eds). Vascular Access for Hemodialysis. Gore & Associates, 1991, pp 145-157.
11. Pastan S, Soucie JM, McClellan WM. Vascular access and increased risk of death among hemodialysis patients. Kidney Int 2002; 62: 620-626.
12. 2001 Report, Volume 1: Dialysis and Renal Transplantation, Canadian Organ Replacement Register. 2001.
13. Clark TW, Hirsch DA, Jindal KJ et al. Outcome and prognostic factors of restenosis after percutaneous treatment of native hemodialysis fistulas. J Vasc Interv Radiol 2002; 13: 51-59.
14. Palder SB, Kirkman RL, Whittemore AD et al. Vascular access for hemodialysis. Patency rates and results of revision. Ann Surg 1985; 202: 235-239.
15. Cohen MA, Kumpe DA, Durham JD et al. Improved treatment of thrombosed hemodialysis access sites with thrombolysis and angioplasty. Kidney Int 1994; 46: 1375-1380.
16. Beathard GA. Percutaneous transvenous angioplasty in the treatment of vascular access stenosis. Kidney Int 1992; 42: 1390-1397.
17. Guerra A, Raynaud A, Beyssen B et al. Arterial percutaneous angioplasty in upper limbs with vascular access devices for haemodialysis. Nephrol Dial Transplant 2002; 17: 843-851.
18. Turmel-Rodrigues L, Pengloan J, Rodrigue H et al. Treatment of failed native arteriovenous fistulae for hemodialysis by interventional radiology. Kidney Int 2000; 57: 1124-1140.
19. Xue JL, Dahl D, Ebben JP et al. The association of initial hemodialysis access type with mortality outcomes in elderly Medicare ESRD patients. Am.J Kidney Dis 2003; 42: 1013-1019.
20. Dhingra R. Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int 2001; 60: 1443-1451.
21. Polkinghorne KR, McDonald SP, Atkins RC et al. Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol 2004; 15: 477-486.
22. Weinstein MC, O'Brien B, Hornberger J et al. Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices - Modeling Studies. Value Health 2003; 6: 9-17.
23. Depner TA, Krivitski NM. Clinical measurement of blood flow in hemodialysis access fistulae and grafts by ultrasound dilution. ASAIO J 1995; 41: M745-M749.
24. Sonnenberg F, Beck J. Markov models in medical decision making: A practical guide. Med Decision Making 1993; 13: 322-338.
25. Lee H, Manns BJ, Taub K et al. Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis 2002; 40: 611-622.
26. Canadian Coordinating Office for Health Technology Assessment Guidelines for economic evaluation of pharmaceuticals: Canada. Canadian Coordinating Office for Health Technology Assessment: Ottawa, 1997.
27. Drummond M, O'Brien B, Stoddart G, Torrance G. Methods for the Economic Evaluation of Health Care Programmes. 2nd edn. Oxford University Press: Oxford, 1997.
28. Tessitore N, Mansucto G, Bedogna V et al. A prospective controlled trial on effect of percutaneous transluminal angioplasty on functioning arteriovenous fistulae survival. J Am Soc Nephrol 2003; 14: 1623-1627.